首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens.
【24h】

Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens.

机译:DNA复制增加在非诱变化学致癌物致癌风险中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

DNA replication is not an error-free process; therefore induction of cell proliferation with the requisite increase in DNA replication may be an important mechanism by which carcinogenesis can be induced by chemicals. Data presented in this overview indicate a positive association between increased cell proliferation and carcinogenesis, and illustrate the value of performing mechanistic studies such as cell proliferation assays in conjunction with short-term tests to further investigate the results of cancer bioassays. Whereas chemically-induced cell proliferation per se may not be sufficient to induce carcinogenesis, it creates a favorable environment for tumor development. There are two types of chemically-induced cell proliferation, mitogenic and cytotoxic, and they have different consequences regarding the mechanism of carcinogenesis of a chemical. Mitogenic chemical such as phenobarbital, oxazepam, and the peroxisome proliferating agents exert a short-term cell proliferative response that may exert its primary effect in carcinogenesis at the promotion stages. It is not clear at what stage(s) cytotoxic agents such as methapyrilene, alpha 2u-globulin inducers or saccharin exert their effects in carcinogenesis. A confounding factor in evaluation of cell proliferation in risk assessments is the production of chemical specific pleiotropic effects that may contribute to the carcinogenicity of a chemical. It is clear that mechanistic studies performed to understand the relationship of sex, species and dose in rodent carcinogenicity assays of chemicals is critical for the extrapolation of such data for human health assessments.
机译:DNA复制不是一个没有错误的过程。因此,以必需的DNA复制增加来诱导细胞增殖可能是化学物质诱导癌变的重要机制。此概述中显示的数据表明细胞增殖与癌变之间呈正相关,并说明了进行机制研究(如细胞增殖测定与短期试验以进一步研究癌症生物测定结果)的价值。尽管化学诱导的细胞增殖本身可能不足以诱导癌变,但它为肿瘤的发展创造了有利的环境。化学诱导的细胞增殖有两种类型,有丝分裂和细胞毒性,它们对化学物质的致癌机理有不同的影响。诸如苯巴比妥,奥沙西m和过氧化物酶体增殖剂之类的有丝分裂化学物质会产生短期细胞增殖反应,这可能在促进阶段在癌变中发挥主要作用。尚不清楚细胞毒剂(例如甲萘丙啶,α2u-球蛋白诱导剂或糖精)在什么阶段发挥其在致癌作用中的作用。在风险评估中评估细胞增殖的一个混杂因素是产生化学特异的多效效应,该效应可能有助于化学物质的致癌性。显然,进行机械研究以了解化学物质的啮齿类动物致癌性试验中的性别,物种和剂量之间的关系,对于将此类数据外推到人体健康评估中至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号